Dow Up0.36% Nasdaq Up0.12%

BioCryst Pharmaceuticals, Inc. (BCRX)

12.61 Down 0.48(3.67%) 4:00PM EDT
|After Hours : 12.61 Down 0.00 (0.02%) 4:56PM EDT
Analyst OpinionGet Analyst Opinion for:
Recommendation Summary*
Mean Recommendation (this week):2.2
Mean Recommendation (last week):2.2

* (Strong Buy) 1.0 - 5.0 (Sell)

Price Target Summary
Mean Target:17.73
Median Target:18.00
High Target:24.00
Low Target:9.00
No. of Brokers:11

Data provided by Thomson/First Call

Upgrades & Downgrades History
DateResearch FirmActionFromTo
Feb 28, 2014OppenheimerInitiated Perform
Feb 20, 2014MizuhoInitiated Buy
Feb 18, 2014NeedhamInitiated Buy
Apr 9, 2013MLV & CoUpgradeHoldBuy
Aug 14, 2012WBB SecuritiesDowngradeBuyHold
Sep 29, 2010Rodman & RenshawUpgradeMkt PerformMkt Outperform
Jan 29, 2010WBB SecuritiesInitiated Buy
Oct 13, 2009JMP SecuritiesInitiated Mkt Outperform
Sep 20, 2007Caris & CompanyDowngradeAbove AverageAverage
Dec 11, 2006Caris & CompanyDowngradeAbove AverageAverage

More Upgrades & Downgrades for BCRX

Data provided by - Take a free trial
Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

Recommendation Trends
Current MonthLast MonthTwo Months AgoThree Months Ago
Strong Buy1100

Data provided by Thomson/First Call

Currency in USD.